Article
COLIA1 Sp1 polymorphism predicts response of femoral neck bone density to cyclical etidronate therapy.
Calcified tissue international - 1 Mar 2002
Qureshi A M, Herd R J, Blake G M, Fogelman I, Ralston S H
Abstract excerpt
Genetic factors are important in the pathogenesis of osteoporosis but less is known about their possible role in predicting response to anti-osteoporotic therapy. Previous studies have shown that a polymorphic Sp1 binding site in the collagen type 1 alpha 1 gene (COLIA1) is associated with bone mineral density (BMD) and osteoporotic vertebral fracture. In this study we sought to determine if the COLIA1 Sp1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
